The health and beauty retailer, which has a market worth of over $55bn, has been in preliminary talks with private equity firms over recent months discussing what would be one of the biggest ever leveraged buyouts, according to Reuters.

Walgreens has brought in investment bank Evercore Partners to investigate whether the deal can be done. However, sources close to the situation told Reuters that a deal is far from certain.